Clinical Trial Matching Bowhead Health focuses on accelerating oncology trial matching to oncologists, presenting a sales opportunity to integrate radiogenomics and imaging-driven candidate identification into trial recruitment workflows for faster and more accurate patient enrollment.

Radiogenomics Platform Recent news indicates development of a radiogenomics platform that links imaging to genomic mutations to guide personalized treatment and trial matching, suggesting potential upsell to existing customers through imaging analytics and precision medicine capabilities.

Mayo Platform Access Enrollment in the Mayo Clinic Platform Accelerate program signals credibility and potential collaboration channels with large health systems, offering a doorway to pilot programs, co-development, and expanded deployment opportunities.

Global Partnerships Active partnerships with cancer centers across the US, Europe, Canada and India indicate readiness to scale; opportunities exist to commercialize cross-border trials, compliance solutions, and region-specific data workflows.

Early-Stage Revenue With revenue under $1M and a small team, Bowhead Health is poised for rapid customer acquisition and upsell into mid- to large-institution networks seeking efficiency gains in trial matching and radiogenomics-enabled care.